<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/ACE18B20-4218-4BD9-A733-D20E6FFAA05A"><gtr:id>ACE18B20-4218-4BD9-A733-D20E6FFAA05A</gtr:id><gtr:firstName>Jeremy</gtr:firstName><gtr:otherNames>Stuart</gtr:otherNames><gtr:surname>Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700829"><gtr:id>89F09C41-652D-4DBC-812B-7240E8C92411</gtr:id><gtr:title>Mechanisms of complement-mediated pulmonary immunity to Streptococcus pneumoniae</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700829</gtr:grantReference><gtr:abstractText>Pneumonia is one of the most common infections worldwide, and is most often caused by the bacteria Streptococcus pneumoniae (otherwise known as the pneumococcus). As a consequence pneumococcus is an important cause of premature death, killing over a million children per year. We urgently need to understand how the body prevents the pneumococcus from causing lung infections in order to design effective methods of reducing this toll. One important component of the bodies immune system for preventing pneumococcus from causing lung infections is the complement system, a series of proteins that can bind to bacteria and help prevent disease. However, exactly how complement stops the pneumococcus from causing pneumonia is not known, and the aim of this proposal is to identify the mechanisms by which complement helps lung defences control infection by pneumococcus. One possibility is that complement bound to the bacteria help white cells in the lung ingest and kill the pneumococcus, and the other possibility is that activation of complement proteins act as a warning signal that results in the body directing its immune defences to the lung. The proposal will evaluate the degree to which these two possibilities contribute to lung defence against pneumococcus. The effect of complement on the interactions of pneumococcus with two different types of human white cells will be investigated to identify which of these two cell types are likely to use complement during infection to kill the pneumococcus. The results will be reinforced by experiments infecting mice that have been genetically engineered so that they are deficient in complement with pneumococcus. Using these experiments we will be able to assess the effects of loss of complement on white cell functions and the bodies response during the actual development of pneumonia, data which the complexity of the immune response to infection makes impossible to obtain without using animal experiments. The information obtained from the proposal will substantially improve our knowledge of how the lungs defend against the pneumococcus, and should lead to future therapies aimed at preventing or treating this important cause of lethal infection. The results will be published in science journals, and important results disseminated to the general public via the UCL website and publicity office.</gtr:abstractText><gtr:technicalSummary>Pneumonia due to Streptococcus pneumoniae is a common and serious disease, responsible for significant morbidity and mortality in otherwise healthy adults and children. Severe pneumonia has a mortality of 25% despite treatment with appropriate antibiotics, and there is an increasing incidence of antibiotic resistance amongst clinical isolates of S. pneumoniae. Hence a comprehensive understanding of the interactions of S. pneumoniae with the host immune system is necessary for the development of better therapeutic and preventative strategies. One important element of host immunity to S. pneumoniae is the complement system. Laboratory and clinical data suggest that complement, as well as preventing systemic infection, also has a significant role in helping control S. pneumoniae infection during the early stages of pneumonia. However which mechanisms mediate complement-dependent immunity to S. pneumoniae within the lungs and which complement pathways are involved has not been defined. Mechanisms of complement-dependent immunity in the lungs are likely to include either improved phagocytosis by alveolar macrophages or neutrophils (which are recruited to the lung within a few hours of S. pneumoniae infection) or enhanced inflammatory responses to the infection. The overall aim of this proposal is to take advantage of new scientific developments to investigate how complement assists immunity during early pneumonia, using assays of phagocyte function and animal models of infection. The contribution and the specific effects of different complement pathways on the interactions of S. pneumoniae with pulmonary phagocytes will be characterised. Bacteria will be incubated in sera deficient in specific complement components, mixed with ex-vivo human neutrophils and alveolar macrophages and assays for phagocytosis, bacterial killing, phagolysosomal maturity, and phagocyte activation performed. Mouse models of infection in complement deficient mice will be used to assess the roles of different complement pathways during early S. pneumoniae pneumonia. The effects of complement deficiencies on C3b deposition on S. pneumoniae in the lungs, phagocytosis by alveolar macrophages and neutrophils, bacterial replication, and the development of the inflammatory response and white cell recruitment will be characterised. Comparing the data obtained from human samples and mouse models of infections will allow a thorough characterisation of the likely effects of complement during early S. pneumoniae pneumonia in humans. The results will provide important insights into complement dependent immunity to pulmonary pathogens, why certain patients with complement deficiencies are susceptible to S. pneumoniae pneumonia, and valuable data for the design of new strategies to prevent this common and serious disease.</gtr:technicalSummary><gtr:fund><gtr:end>2011-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>307666</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Medicine</gtr:department><gtr:description>Comparative virulence of Streptococcous pneumoniae and Streptococcus mitis</gtr:description><gtr:id>4CD81AB7-1D5B-4CED-B539-0716E53AA773</gtr:id><gtr:impact>presentation of various abstracts at conferences; poster prize for best poster at Europneumo July 2015
one paper: Rukke HV, Kalluru RS, Repnik U, Gerlini A, Jos&amp;eacute; RJ, Periselneris J, Marshall H, Griffiths G, Oggioni MR, Brown JS, Petersen FC. Protective Role of the Capsule and Impact of Serotype 4 Switching on Streptococcus mitis. Infect Immun. 2014 Sep;82(9):3790-801</gtr:impact><gtr:outcomeId>56df0a9abdfd64.71684732-1</gtr:outcomeId><gtr:partnerContribution>Shared supervision of a PhD student</gtr:partnerContribution><gtr:piContribution>Joint BBSRC PhD fellowship with Dr Laurent Bozec</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Welding fumes and lung immunity</gtr:description><gtr:id>FD7FDE6C-E4A8-4187-9FA3-68589F4FFDAC</gtr:id><gtr:impact>Colt foundation project grant. Identification of the mechanism for the association between pneumococcal pneumonia and exposure to welding fumes. Prof J. Grigg, J.S.Brown &amp;pound;95,000</gtr:impact><gtr:outcomeId>BfKtSSd8sYa-1</gtr:outcomeId><gtr:partnerContribution>The in vitro assessment; the researcher is based at Queen Mary's</gtr:partnerContribution><gtr:piContribution>Collaborative research - we do mainly the animal models of infection work</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oslo</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Oral Biology</gtr:department><gtr:description>Protection to Streptococcus pneumoniae by commensal streptococci</gtr:description><gtr:id>2571F545-2581-4C7E-8D27-81062B29D1EE</gtr:id><gtr:impact>none as yet</gtr:impact><gtr:outcomeId>56df0913ee10f5.20074351-1</gtr:outcomeId><gtr:partnerContribution>they led the application</gtr:partnerContribution><gtr:piContribution>I am a coPI on a successful grant application to the Research Council of Norway (award &amp;pound;650,000)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>650000</gtr:amountPounds><gtr:country>Norway, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Research Council of Norway</gtr:fundingOrg><gtr:id>2E0F79C0-F1BF-4932-90AF-AEDEE355EB73</gtr:id><gtr:outcomeId>56df0b26d07704.14485307</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC PhD fellowship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>A0E0DDFC-E378-47BD-9956-3069738E5857</gtr:id><gtr:outcomeId>56df0bb7d02128.38526972</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>95000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>The Colt Foundation</gtr:fundingOrg><gtr:id>9A955DB2-66F0-415E-A0C3-41C1B5168D44</gtr:id><gtr:outcomeId>abVZqcH7mER</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>5F821AE1-7FD4-4CF3-851D-348926E4937D</gtr:id><gtr:outcomeId>DPbYhPbkHRC</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>358711</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>response mode</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1D6C41E7-7CCF-407A-8EEB-02638BCC21C9</gtr:id><gtr:outcomeId>ccBmRWJFkJC0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>228751</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical PhD fellowship</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>7A267300-FB86-45A8-962D-395D1F7C151B</gtr:id><gtr:outcomeId>PZ12L2XQm6A</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Lecture to GulfThoracic conference</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>0690EECB-E91A-419D-B819-6493BC0EDDE9</gtr:id><gtr:impact>I gave two lectures on the care of pneumonia patients at the GulfThoracic conference, Dubai; by educating the healthcare workforce these should improve provision of care for these patients in the Middle East</gtr:impact><gtr:outcomeId>iG3Wy8iYYWL</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Thoracic Society short course in lung infection</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6E5001C0-F6BF-484D-81DC-9AD6565B4352</gtr:id><gtr:impact>I co-organised and co-chaired (and delivered a lecture) on a British Thoracic Society sponsored short course in lung infection at the annual summer meeting - by educating the audience this should improve provision of care for patients with lung infection</gtr:impact><gtr:outcomeId>YqcWE96DdmD</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Clinical Reference Group membership</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4220AC98-228F-4C86-984B-A91172775DFE</gtr:id><gtr:impact>responsible for the design and implementation of national commissioning for subspecialty care for specific areas of respiratory medicine- implemented subspecialty care for three separate conditions across England</gtr:impact><gtr:outcomeId>iwvZAEf22AM</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Royal College Regional training day lectures (three in total, a fourth in Oct 2014)</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>F82C370E-C821-4484-BF99-716762AE073D</gtr:id><gtr:impact>I have given 2012-2013 three lectures to Royal College of Physician regional training days on various aspects of clinical care for patients with pneumonia; a fourth lecture is planned for the national training conference October 2014</gtr:impact><gtr:outcomeId>nZHA8xkf64C</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE pneumonia guidelines</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>462CF881-8DF6-4C0A-9931-8D3053FBC667</gtr:id><gtr:outcomeId>azuLKDJ3NQV</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Bacterial strains, both wild-type and mutant</gtr:description><gtr:id>0C997B22-46A5-4E3F-BA1E-73D4D7A1CEE6</gtr:id><gtr:impact>research using these strains has contributed to various papers</gtr:impact><gtr:outcomeId>tdr2ePjPcA4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>bacterial strains</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D287A54F-DFBA-4BD6-94EF-CAE46C02F0EC</gtr:id><gtr:title>Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9879e36e918e21a0f6e5058aae4a69b7"><gtr:id>9879e36e918e21a0f6e5058aae4a69b7</gtr:id><gtr:otherNames>Hyams C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>pm_15413_23_23147038</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7B1B575-AD3E-4ADC-A841-DED9B4BEDB7E</gtr:id><gtr:title>TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fee2b10c4191f76ee0f698a1eed4e25d"><gtr:id>fee2b10c4191f76ee0f698a1eed4e25d</gtr:id><gtr:otherNames>Tomlinson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>542bc87e192391.49498740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90F38D11-FC92-4A53-8D8F-ABA8D7CC9CF2</gtr:id><gtr:title>Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fa147a5ed9c5a4991da767cb5b20dd9"><gtr:id>0fa147a5ed9c5a4991da767cb5b20dd9</gtr:id><gtr:otherNames>Cohen JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_15413_23_22561489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27B50FCF-57B7-4041-AA12-3F57DBCA593F</gtr:id><gtr:title>Infection with conditionally virulent Streptococcus pneumoniae ?pab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5962392ee65b5f084b234a036abc0a0"><gtr:id>d5962392ee65b5f084b234a036abc0a0</gtr:id><gtr:otherNames>Chimalapati S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>cbX3g1RNadm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25185B5D-35A4-4FAE-BAA1-39FD84354781</gtr:id><gtr:title>The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b0eded43fabe82396d341632a105097"><gtr:id>7b0eded43fabe82396d341632a105097</gtr:id><gtr:otherNames>Yuste J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>kxff1dnJZjb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEBEEEF1-CBD3-470D-86D7-FF32D62EDA30</gtr:id><gtr:title>Effects of deletion of the Streptococcus pneumoniae lipoprotein diacylglyceryl transferase gene lgt on ABC transporter function and on growth in vivo.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5962392ee65b5f084b234a036abc0a0"><gtr:id>d5962392ee65b5f084b234a036abc0a0</gtr:id><gtr:otherNames>Chimalapati S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15413_23_22911788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12DBAD41-0987-45F4-B355-FD5D70C6903F</gtr:id><gtr:title>Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fa147a5ed9c5a4991da767cb5b20dd9"><gtr:id>0fa147a5ed9c5a4991da767cb5b20dd9</gtr:id><gtr:otherNames>Cohen JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pgyr7LaRakg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D0A3860-D966-4C25-AE86-22D1EAC46247</gtr:id><gtr:title>The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9879e36e918e21a0f6e5058aae4a69b7"><gtr:id>9879e36e918e21a0f6e5058aae4a69b7</gtr:id><gtr:otherNames>Hyams C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>pm_15413_13_19948837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82A003C3-ED1A-4C1E-943A-E02916FD75FE</gtr:id><gtr:title>Importance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89da51acca1fb8397bff4e01ec87d721"><gtr:id>89da51acca1fb8397bff4e01ec87d721</gtr:id><gtr:otherNames>Camberlein E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>56df06f43468b2.59839401</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7B760BE-4240-4BCD-90BF-77B7CBFD73FB</gtr:id><gtr:title>Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9879e36e918e21a0f6e5058aae4a69b7"><gtr:id>9879e36e918e21a0f6e5058aae4a69b7</gtr:id><gtr:otherNames>Hyams C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>Jg7gg3CjoZy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AB69AC5-FA9D-41EE-A631-B3E38F091DC4</gtr:id><gtr:title>Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2d8cc098273d94eba03b142822ead93"><gtr:id>a2d8cc098273d94eba03b142822ead93</gtr:id><gtr:otherNames>Sanchez CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>MCeVcVwxm3d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73044056-00E9-449E-BF9F-9ED253ADDCDF</gtr:id><gtr:title>Impaired opsonization with complement and phagocytosis of Streptococcus pyogenes in sera from subjects with inherited C2 deficiency.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b0eded43fabe82396d341632a105097"><gtr:id>7b0eded43fabe82396d341632a105097</gtr:id><gtr:otherNames>Yuste J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>fUwRFNZ3vUJ</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700829</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>